MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278
Each year, more than 80,000 cases of bladder cancer are diagnosed in the United States. Today, advancements in treating all stages of bladder cancer improve outcomes and overall quality of life. While many patients are diagnosed in the early stages, bladder cancer has a high rate of recurrence and may progress, so partnering with physicians you trust is crucial for managing your bladder cancer and maintaining long-term health.
The University of Chicago Medicine's urologic cancer program is one of the most experienced programs in the country. Our expert bladder cancer team offers innovative treatment options, novel therapies and a comprehensive, personalized care plan for each patient. Whether you are diagnosed with early-stage bladder cancer, late-stage metastatic cancer or have recurrent cancer, our physicians are dedicated to providing you the most advanced, individualized treatment solutions.
Bladder cancer is a complex disease that often requires a combination of therapies to reach the most successful outcome. With our collaborative, multidisciplinary team of experts committed to your health, you can feel confident that we will deliver unparalleled care. These internationally-recognized specialists work closely together, and with you, to determine the best treatment strategy for your specific diagnosis and lifestyle needs.
UChicago Medicine performs more radical cystectomies (bladder removal surgery) than any other institution in the Midwest region. We are proven, innovative leaders in the surgical treatment of bladder cancer, including bladder reconstructive surgery, minimally invasive surgery and nerve-sparing techniques. Our experts combine the highest level of skill with the latest advancements to deliver first-class care.
Learn more about bladder cancer treatment by cancer stage:
Our researchers and clinicians are at the forefront of bladder cancer care. Through leading-edge basic, translational and clinical research, we are exploring new treatment options for patients in all stages of disease. We are also investigating ways to personalize medicine for each patient, providing therapies that are more effective with fewer side effects. Additionally, we offer our patients the latest treatments before they are widely available through our clinical trials.